ovarian cancer awareness in the uk, page-22

i'm seriously struggling to find a reason to sell this share lol. this is the best long term share in my portfolio by far.

basically because:
-Market cap way undervalued IMO (should be over 3+ times higher)

-dividends will flow eventually, and would be a good percentage ratio to revenue.

-at least 3 more countries may take up ovplex which are in discussions

-small amount of issued shares and no options

-product is Asia product of the year 2010

-management seem to be striving for multiple expansion paths

-healthlinx are working now on improving the already good 97% success rate of Ovplex

-back-burner product - ClearIT

the list goes on, this is definately not moving from my list and it's just the beginning :)

all in my opinion of course.

Marc